The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
Sascha Ansen
No relevant relationships to disclose
Anne Maria Schultheis
No relevant relationships to disclose
Martin Hellmich
No relevant relationships to disclose
Thomas Zander
No relevant relationships to disclose
Michael Brockmann
No relevant relationships to disclose
Erich Stoelben
No relevant relationships to disclose
Harry J.M. Groen
No relevant relationships to disclose
Wim Timens
No relevant relationships to disclose
Reinhard Buettner
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Roman K. Thomas
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Sven Perner
No relevant relationships to disclose
Juergen Wolf
Consultant or Advisory Role - Bristol-Myers Squibb; Roche/Genentech
Honoraria - Bristol-Myers Squibb; Roche/Genentech